Successful treatment of a child with T/myeloid acute bilineal leukemia associated with TLX3/BCL11B fusion and 9q deletion

Pediatric Blood and Cancer

Volumn 56, Issue 3, 2011, Pages 467-469

  Oliveira, Jennifer L ^a   Kumar, Riten ^a   Khan, Shakila P ^a   Law, Mark E ^a   Erickson Johnson, Michele ^a   Oliveira, Andre M ^a   Ketterling, Rhett P ^a   Dogan, Ahmet ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acute bilineal leukemia; Ambiguous; BCL11B; Biphenotypic; HOX11L2; MPAL; T(5 ; 14), 9q; T ALL; T myeloid; TLX3

Indexed keywords

ACUTE BILINEAL LEUKEMIA; ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BCL11B GENE; CASE REPORT; CELL LINEAGE; CHILD; CHROMOSOME 13Q; CHROMOSOME 9Q; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; CORD BLOOD STEM CELL TRANSPLANTATION; ENGRAFTMENT; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE FUSION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOBLAST; MALE; MYELOID PROGENITOR CELL; PRIORITY JOURNAL; SCHOOL CHILD; T CELL LEUKEMIA; TLX3 GENE;

ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; CHILD; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 9; COMBINED MODALITY THERAPY; HOMEODOMAIN PROTEINS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, BIPHENOTYPIC, ACUTE; LEUKEMIA, MYELOID, ACUTE; LEUKEMIA, T-CELL; MALE; ONCOGENE PROTEINS, FUSION; REMISSION INDUCTION; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE DELETION; TRANSLOCATION, GENETIC; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEINS;

EID: 78651102843     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22850     Document Type: Article

References (13)

1. Swerdlow S, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008.
2. Peniket A, Wainscoat J, Side L, et al. Del (9q) AML: Clinical and cytological characteristics and prognostic implications. Br J Haematol 2005; 129: 210-220.
3. Akashi K, Shibuya T, Harada M, et al. Interstitial 9q deletion in T-lymphoid/myeloid biphenotypic leukaemia. Br J Haematol 1992; 80: 172-177.
4. Ferrara F, Scognamiglio M, Di Noto R, et al. Interstitial 9q deletion is associated with CD7+ acute leukemia of myeloid and T lymphoid lineage. Leukemia 1996; 10: 1990-1992.
5. Kelly K, Murphy P. Aplastic anaemia preceding acute lymphoblastic leukaemia in an adult with isolated deletion of chromosome 9q. Leuk Res 2008; 32: 1936-1938 [Epub 2008 May 1919].
6. Su XY, Della-Valle V, Andre-Schmutz I, et al. HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32). Blood 2006; 108: 4198-4201 [Epub 2006 August 4122].
7. Rubnitz JE, Onciu M, Pounds S, et al. Acute mixed lineage leukemia in children: The experience of St Jude Children's Research Hospital. Blood 2009; 113: 5083-5089 [Epub 2009 January 5088].
8. Weir EG, Ali Ansari-Lari M, Batista DA, et al. Acute bilineal leukemia: A rare disease with poor outcome. Leukemia 2007; 21: 2264-2270 [Epub 2007 July 2265].
9. Zomas AP, Swansbury GJ, Matutes E, et al. Bilineal acute leukemia of B and T lineage with a novel translocation t(9;17)(p11;q11). Leuk Lymphoma 1997; 25: 179-185.
10. Gerr H, Zimmermann M, Schrappe M, et al. Acute leukaemias of ambiguous lineage in children: Characterization, prognosis and therapy recommendations. Br J Haematol 2010; 149: 84-92. [Epub 2010 January 18].
11. Van Vlierberghe P, Homminga I, Zuurbier L, et al. Cooperative genetic defects in TLX3 rearranged pediatric T-ALL. Leukemia 2008; 22: 762-770 [Epub 2008 January 2010].
12. Mauvieux L, Leymarie V, Helias C, et al. High incidence of Hox11L2 expression in children with T-ALL. Leukemia 2002; 16: 2417-2422.
13. Su X, Drabkin H, Clappier E, et al. Transforming potential of the T-cell acute lymphoblastic leukemia-associated homeobox genes HOXA13, TLX1, and TLX3. Genes Chromosomes Cancer 2006; 45: 846-855.